SMOC1 and microphthalmia with limb anomalies: Although the molecular basis of the developmental pathology associated with OAS remains to be elucidated, support for SMOC-1 mediated BMP antagonism as a component is provided by human and mouse genetic data that indicate the importance of BMP signalling in both limb [56], [57] and eye [8], [58], [59] development.